Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:2287-2293
Published online before print August 19, 2004, doi: 10.1161/01.STR.0000140636.30204.da
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/10/2287    most recent
01.STR.0000140636.30204.dav1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frösen, J.
Right arrow Articles by Jääskeläinen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frösen, J.
Right arrow Articles by Jääskeläinen, J.
Related Collections
Right arrow Smooth muscle proliferation and differentiation
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage

(Stroke. 2004;35:2287.)
© 2004 American Heart Association, Inc.


Original Contributions

Remodeling of Saccular Cerebral Artery Aneurysm Wall Is Associated With Rupture

Histological Analysis of 24 Unruptured and 42 Ruptured Cases

Juhana Frösen, MD; Anna Piippo, MB; Anders Paetau, MD PhD; Marko Kangasniemi, MD PhD; Mika Niemelä, MD PhD; Juha Hernesniemi, MD PhD Juha Jääskeläinen, MD PhD

From the Neurosurgery Research Group (J.F., A. Piippo, A. Paetau, M.K., M.N., J.H., J.J.), Biomedicum Helsinki, Helsinki, Finland; the Departments of Neurosurgery (J.F., A. Piippo, M.N., J.H.) and Pathology (A. Paetau), and the Medical Imaging Center (M.K.), Helsinki University Central Hospital, Helsinki, Finland; and the Department of Neurosurgery (J.J.), Kuopio University Hospital, Kuopio, Finland.

Correspondence to Dr Juhana Frösen, Neuroscience Program, Room B408a2, Haartmaninkatu 8, Biomedicum Helsinki, Helsinki, Finland. E-mail juhana.frosen{at}hus.fi


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background and Purpose— The cellular mechanisms of degeneration and repair preceding rupture of the saccular cerebral artery aneurysm wall need to be elucidated for rational design of growth factor or drug-releasing endovascular devices.

Methods— Patient records, preoperative vascular imaging studies, and the snap-frozen fundi resected after microsurgical clipping from 66 aneurysms were studied. Immunostainings for markers of smooth muscle cell (SMC) phenotype, proliferation, and inflammatory cell subtypes and TUNEL reaction were performed.

Results— Unruptured (24) and ruptured (42) aneurysms had similar dimensions (median diameter in unruptured 6 mm; median in ruptured 7 mm; P=0.308). We identified 4 basic types of aneurysm wall that associated with rupture: (1) endothelialized wall with linearly organized SMCs (17/66; 42% ruptured), (2) thickened wall with disorganized SMCs (20/66; 55% ruptured), (3) hypocellular wall with either myointimal hyperplasia or organizing luminal thrombosis (14/66; 64% ruptured), and (4) an extremely thin thrombosis-lined hypocellular wall (15/66; 100% ruptured). Apoptosis, de-endothelialization, luminal thrombosis, SMC proliferation, and T-cell and macrophage infiltration associated with rupture. Furthermore, macrophage infiltration associated with SMC proliferation, and both were increased in ruptured aneurysms resected <12 hours from rupture, suggesting that these were not just reactive changes.

Conclusions— Before rupture, the wall of saccular cerebral artery aneurysm undergoes morphological changes associated with remodeling of the aneurysm wall. Some of these changes, like SMC proliferation and macrophage infiltration, likely reflect ongoing repair attempts that could be enhanced with pharmacological therapy.


Key Words: cerebral aneurysm • inflammation • intracranial aneurysm • rupture


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Saccular cerebral artery aneurysms (SCAAs) in the cerebral artery bifurcations are the most common cause of subarachnoid hemorrhage (SAH).1 Known SCAA risk factors include hypertension, smoking, heavy alcohol consumption, and female gender.2,3 Some SCAA cases are familial,4 with a linkage to 19q13.3 area in the Finnish population5,6 and to the 7q11 area in the Japanese population.7 The mechanisms of how these factors predispose to the formation or rupture of the SCAA wall are not known.

There are few reports about SCAA wall histology,8–13 and the cellular mechanisms of SCAA rupture are unknown. Characterization of these mechanisms is mandatory for development of targeted treatment to prevent SCAA growth and rupture. Such a treatment could be delivered either systemically or by using coated endovascular devices such as stents or coils.14,15

SCAA wall is subjected to increasing hemodynamic stress and likely becomes unstable and undergoes morphological changes before rupture. The cellular mechanisms of adaptation to increased hemodynamic stress in normal arterial wall are proliferation and luminal migration of smooth muscle cells (SMCs).16,17 These cellular mechanisms are partly controlled by cytokines released by inflammatory cells infiltrating the vascular wall.18 In addition to these 3 mechanisms, the SCAA wall is prone to form thrombosis lining of the luminal wall because of altered flow conditions.19 Organization of this thrombus lining thickens the wall.

Our aim was to characterize these cellular mechanisms in a series of human SCAA fundi (24 unruptured and 42 ruptured) resected after microsurgical clipping of the SCAA neck from patients that did not significantly differ in age or gender, or in aneurysm size or location.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Human SCAA Samples
SCAA samples were obtained during microsurgery by resecting the aneurysm sac distal to the clip closing the neck (J.H., M.N., Department of Neurosurgery, Helsinki University Central Hospital; years 2000 to 2002; 220 aneurysms operated per year). The tissue samples were snap-frozen in liquid nitrogen and stored in –70°C. The study was approved by the ethics committee of the Departments of Neurology, Neurosurgery, Otorhinolaryngology, and Ophthalmology at the Helsinki University Central Hospital.

Histology and Immunohistochemistry
Snap-frozen tissue samples were cryosectioned at 4 µm. For histology, sections were stained with hematoxylin-eosin (HE) and Weigert-van Gieson methods. For immunohistochemistry, sections were first incubated for 30 minutes at room temperature in PBS with 1.5% horse serum, and then overnight at 4°C with a monoclonal mouse anti-human primary antibody (Table 1) at 1:200 or 1:100 dilution in PBS with 1.5% horse serum. The primary antibody was detected after blocking endogenous peroxidase by 20 minutes incubation at room temperature in PBS with 0.1% hydrogen peroxide using the horseradish peroxidase-conjugated Vectastain anti-mouse kit (Vector Laboratories) and diaminobenzidine (Sigma-Aldrich). Sections were background stained with Gill’s hematoxylin (Vector Laboratories). Substitution of the primary antibody with an irrelevant monoclonal antibody (anti-bromodeoxyuridine, clone BU20A; DAKO) or with PBS with 1.5% horse serum served as negative controls. Anonymized sections from human tonsils served as positive controls. TUNEL stainings were performed using the peroxidase-conjugated in situ cell death detection kit (Roche Diagnostics).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Monoclonal Mouse Anti-Human Antibodies Used in the Study

Histological Analysis
All histological quantifications were performed blinded for the rupture status. Two blinded observers (J.F., A. Paetau) performed classification of the SCAA wall structure. In addition, preservation of elastic laminas and endothelium, as well as the presence of atherosclerotic calcifications, medial layer degeneration, myointimal hyperplasia (MH), and endoluminal thrombosis, were evaluated (J.F.). To quantitate the number of fibroblasts and myofibroblasts, the number of fibroblast antigen+ cells was counted at x40 magnification from 2 active areas, and results are given as the mean value of the ratio of these cells and total cell number in the 2 active areas. To quantitate proliferation, the mean value of Ki67+ cells was quantitated similarly.

To quantitate inflammatory cell infiltration, the number of the CD45+, CD3+, CD68+, CD163+, and CD11b+ inflammatory cells was counted from a standardized grid area using x40 magnification (0.0625 mm2) from 2 active areas of the SCAA wall. The mean value for the density of positive cells (number of cells/grid area) was calculated. The ratios and densities were calculated separately for the SCAA wall and for the areas of MH/organizing thrombosis (OT) when present.

Clinical and Radiological Data
Clinical data were collected from the patients’ medical records. Dimensions of the aneurysms were measured from preoperative vascular imaging studies: computed tomography, magnetic resonance angiography, or digital subtraction angiography.

Statistics
Statistics were calculated using the NCSS 2000 (NCSS Statistical Software). For categorical variables, proportions were calculated and {chi}2 independence test was used. For numeric variables, median and range were calculated, and Mann-Whitney U test and Kruskall-Wallis multiple comparison test were used. Logistic regression and multiple linear regression were used in multivariable analysis. {alpha}-Level was 0.05.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Patients and SCAAs
Patients with unruptured (n=24) or ruptured (n=42) SCAAs did not differ by age or gender (Table 2). The aneurysm neck and fundus sizes were similar (Table 2), and the most frequent locations were middle cerebral artery (67% in unruptured versus 41% in ruptured) and anterior communicating artery (AComA; 8% in unruptured versus 21% in ruptured). Secondary pouches in preoperative angiographies were seen in 30% of unruptured and in 67% of ruptured SCAAs (P=0.005).


View this table:
[in this window]
[in a new window]
 
TABLE 2. Patients and SCAAs

Histological Types of SCAA Walls
SCAA walls of the 6 familial aneurysm patients did not differ from the 60 sporadic ones. Lack of elastic laminas was a common feature in the SCAAs studied. Atherosclerotic calcifications were seen in only 5 unruptured and 2 ruptured cases. However, pads of MH or MH-like disorganized wall structure occurred in both groups (Table 2). Four basic types of SCAA wall structure were distinguished (Figure 1A through 1D): type A (n=17), endothelialized wall with linearly organized SMC; type B (n=20), thickened wall with disorganized SMC; type C (n=14), hypocellular wall with either MH or OT; and type D (n=15), an extremely thin thrombosis-lined hypocellular wall. The prevailing wall type in the sample significantly associated (P=0.004) with rupture: 42% (7/17) in type A; 55% (11/20) in type B; 64% (9/14) in type C; and 100% (15/15) in type D. Symptoms suggestive of minor leaks29 before diagnosed SAH were recorded in 12 patients (29%), and minor leaks were associated with the D-type wall (P=0.011). Several aneurysm walls were heterogeneous with gradual change from types A or B to types C or D, mostly in the neck to fundus direction. The wall type was not associated with aneurysm size (P>0.384) or location (P=0.426) or presence of secondary pouches (P=0.795), but patients with B-type walls were younger (median 47 years) than patients with A-type (median 61 years) or C-type (median 58 years) walls (P=0.021).



View larger version (142K):
[in this window]
[in a new window]
 
Figure 1. The 4 aneurysm wall types identified. A, Endothelialized wall with linearly organized SMCs (17/66; 42% ruptured; CD31 staining). B, Thickened wall with disorganized SMC (20/66; 55% ruptured; myosin heavy chain [MHC] and Ki67 stainings). C, Hypocellular wall with either intimal hyperplasia or organizing luminal thrombosis (14/66; 64% ruptured; HE staining). D, An extremely thin thrombosis-lined hypocellular wall (15/66; 100% ruptured; HE and TUNEL stainings).

Thrombosis and Fibrosis
Fresh thrombosis (Figure 1D) or OT (Figure 1C) lined the luminal aspect in 25% of unruptured and in 70% of ruptured SCAAs (Table 2). SMCs were seen more frequently in luminal OT of ruptured SCAAs (Figure 2, Table 2). OT often had areas so fibrotic that it was difficult to distinguish them from neighboring intimal hyperplasia pads, and they are collectively termed as MH/OT areas in further analysis.



View larger version (119K):
[in this window]
[in a new window]
 
Figure 2. Migration of SMC from the aneurysm wall to a luminal thrombus. A, Immunostaining for myosin heavy chain. B, Immunostaining for fibroblast-antigen. The microphotographs were taken under x10 magnification from consecutive sections of a twice-ruptured right AcomA aneurysm (11x6 mm) in a 28-year-old male. Time from last rupture 14 hours.

Factors Associated With Rupture
Ruptured SCAA walls showed increased de-endothelialization, fresh and organizing luminal thrombosis, proliferation ratio in MH/OT areas, apoptosis ratio outside MH/OT areas, and leukocyte infiltration (CD45, CD3, CD11b, CD68, and CD163) in both areas of the wall (Table 2, Figure 3). These histological changes were not associated with minor leaks. Leukocyte density in MH/OT areas and OT were independent risk factors in logistic regression analysis (R2=0.46; P<0.001 for the model). Fibroblast antigen+ cells occurred equally in the walls of unruptured (39%) and ruptured (46%) SCAAs.



View larger version (40K):
[in this window]
[in a new window]
 
Figure 3. The ratios of fibroblast-antigen+, proliferating and apoptotic cells from total cell number, and the density of inflammatory cells in the wall of unruptured and ruptured aneurysms. Median values and range are given for areas of MH/OT and other areas of the aneurysm wall. Significant differences (P<0.05; Mann-Whitney U test) between unruptured and ruptured aneurysm were found in: (1) the proliferation ratio in MH/OT areas, (2) the ratio of apoptosis in wall areas other than MH/OT, (3) the density of all inflammatory cell types in areas of MH/OT, and (4) the density of CD45+, CD163+, and CD11b+ cells also in other areas.

Leukocyte Infiltration and Cell Proliferation in the SCAA Wall After Rupture
Of the 42 ruptured SCAAs, 35 had been resected between 3.5 and 48 hours after rupture (Table 2). Proliferation ratio, T-cell density (CD3+), and macrophage density (CD163+) were increased in MH/OT areas already before 12 hours from rupture but remained stable in other areas of the wall (Figures 3 and 4Down). Density of CD11b+ cells and CD163+ cells in the MH/OT areas and density of CD68+ cells in other parts significantly associated with proliferation in MH/OT areas in multiple linear regression analysis (R2=0.82; P<0.001 for the model).



View larger version (10K):
[in this window]
[in a new window]
 
Figure 4. Proliferation ratio, T-cell (CD3+) density, and macrophage (CD163+) density in areas of MH/OT in function of time from rupture. Median values are marked on the y-axis with filled boxes.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
The cellular mechanisms of SCAA rupture have to be elucidated for development of locally delivered or systemic drug therapies. We describe in a series of 66 SCAA fundi morphological changes of the SCAA wall that correlate with rupture, association of inflammatory cell infiltration, and SMC proliferation with rupture, and association of macrophage infiltration with SMC proliferation in ruptured SCAA walls.

Morphological Changes in SCAA Wall Preceding Rupture
SCAAs tend to grow over the years.30 Therefore, the SCAA wall has to undergo morphological changes that likely differ in unruptured and ruptured SCAAs. In a previous series of 27 unruptured and 44 ruptured SCAA fundi, Kataoka et al found that thick intima-like walls are mostly unruptured, and very thin and degenerated walls with hyaline deposits mostly ruptured.8 Other previous studies on SCAA walls describe inflammatory cells,9 signs of complement activation,9 increased protease activity,10 variations in SMC phenotype,11 and apoptosis.12

We identified 4 histological SCAA wall types that likely reflect consecutive stages (A through D) of wall degeneration proceeding to rupture. As Kataoka did, we also found that aneurysms with thin hyalinized walls (D-type wall in our series) were ruptured. However, in our series, also as many as 55% (11/20) of thick intima-like walls (B-type) had ruptured. This may reflect differences in Finnish and Japanese SCAA populations. Interestingly, in our series, B-type (thick intima-like) walls occurred in younger patients than A-type (organized) or C-type (hypocellular with luminal thrombosis) walls. Possible association between age and SCAA wall maintenance and repair capacity warrants further studies.

Maintenance and Repair of SCAA Wall
The wall of unruptured SCAAs may remain intact for years.30 Thus, strong maintenance and repair mechanisms are mandatory. Our results suggest that before rupture, the SCAA wall becomes unstable and undergoes morphological changes that start at an undefined time interval before rupture. These changes reflect the effect of risk factors that predispose to rupture as well as the maintenance and repair mechanisms trying to prevent rupture. The factors distinguishing unruptured and ruptured SCAAs in our series were: decellularization, apoptosis, and degeneration of wall matrix; de-endothelialization; thrombus organization; proliferation; and inflammatory infiltration. Most of these are features related to MH (ie, the mechanism of how generally the arterial wall responds to injury or hemodynamic stress).16–18 In MH, proliferation and migration of vascular SMCs lead to formation of a thickened fibroid layer on the luminal surface of the vessel.16–18 During MH formation, the SMCs that migrate from the vascular wall to the luminal surface secrete matrix metalloproteinases that destroy parts of the wall matrix and make the migration of SMCs possible.31 The morphological changes that result from the MH and matrix destruction are collectively referred to as remodeling of the vascular wall.16,17 Although MH is an adaptation mechanism of arteries to hemodynamic stress, in SAH patients, for undefined reasons, vascular wall remodeling was insufficient to prevent SCAA rupture. Paradoxically, in SCAAs, remodeling might even facilitate rupture because of increased matrix proteolysis.31 It would be important to study aneurysms at a few weeks after rupture, but in our series, all but 6 aneurysms were clipped within 48 hours.

Inflammation in SCAA Wall
Ruptured SCAA walls show inflammation.9 It is not known whether inflammation triggers the rupture of the SCAA wall causing SAH. However, it is known that infiltrating leukocytes, mainly T-cells and macrophages, stimulate SMC proliferation in areas of vascular wall thickening.18 We found that T-cell and macrophage infiltration associate with rupture, and furthermore, macrophage infiltration associates with SMC proliferation in the SCAA wall. Therefore, we hypothesize that in the SCAA wall, macrophages may stimulate SMCs to change phenotype and proliferate, thus promoting fibrosis. That SMC proliferation and T-cell and macrophage infiltration were increased in samples resected <12 hours from rupture suggests that these changes were, to some extent, present before rupture because in healthy arterial wall, they occur in response to injury during the first 24 hours or later (T-cell and macrophage infiltration as well as SMC proliferation).17,32

Therapeutic Implications
Only few diagnosed SCAAs will occlude spontaneously.30 It is not known why luminal thrombosis, SMC migration, and vascular wall remodeling fail to prevent rupture and occlude untreated SCAA pouches. Systemic or locally delivered selected agents that stimulate SMC proliferation and migration to luminal thrombus might promote the occlusion. Our data suggest that inflammatory cell infiltration and SMC proliferation increase in the SCAA wall before rupture, and we hypothesize that they are part of the adaptation and repair mechanism of the SCAA wall. Locally delivered selected proinflammatory agents stimulating SMC proliferation and matrix synthesis might reinforce the SCAA wall. In addition, matrix metalloproteinase inhibitors that reduce proteolysis in mechanical arterial wall injury models33,34 might inhibit harmful matrix degradation in the SCAA wall and prevent rupture.


*    Acknowledgments
 
This study was supported by the research funds of the Helsinki University Central Hospital, Finland, and by grants from the Biomedicum Helsinki Foundation. We thank Ilse Pyy, MLT, and Tanja Erikson, MLT, for their excellent technical assistance.

Received February 23, 2004; revision received April 2, 2004; accepted May 9, 2004.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 

  1. Ronkainen A, Hernesniemi J. Subarachnoid haemorrhage of unknown aetiology. Acta Neurochir (Wien). 1992; 119: 29–34.[CrossRef][Medline] [Order article via Infotrieve]
  2. Juvela S, Hillbom M, Numminen H, Koskinen P. Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 1993; 24: 639–646.[Abstract/Free Full Text]
  3. Juvela S. Prehemorrhage risk factors for fatal intracranial aneurysm rupture. Stroke. 2003; 34: 1852–1858.[Abstract/Free Full Text]
  4. Ronkainen A, Hernesniemi J, Puranen M, Niemitukia L, Vanninen R, Ryynanen M, Kuivaniemi H, Tromp G. Familial intracranial aneurysms. Lancet. 1997; 349: 380–384.[CrossRef][Medline] [Order article via Infotrieve]
  5. Wills S, Ronkainen A, van der Voet M, Kuivaniemi H, Helin K, Leinonen E, Frosen J, Niemela M, Jääskeläinen J, Hernesniemi J, Tromp G. Familial intracranial aneurysms: an analysis of 346 multiplex Finnish families. Stroke. 2003; 34: 1370–1374.[Abstract/Free Full Text]
  6. van der Voet, Olson JM, Kuivaniemi H, Dudek DM, Skunca M, Ronkainen A, Niemelä M, Jääskeläinen J, Hernesniemi J, Helin K, Leinonen E, Biswas M, Tromp G. Intracranial aneurysms in Finnish families: confirmation of linkage and refinement of the interval to chromosome 19q13.3. Am J Hum Genet. 2004; 74: 564–571.[CrossRef][Medline] [Order article via Infotrieve]
  7. Onda H, Kasuya H, Yoneyama T, Takakura K, Hori T, Takeda J, Nakajima T, Inoue I. Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. Am J Hum Genet. 2001; 69: 804–819.[CrossRef][Medline] [Order article via Infotrieve]
  8. Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R. Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke. 1999; 30: 1396–1401.[Abstract/Free Full Text]
  9. Chyatte D, Bruno G, Desai S, Todor DR. Inflammation and intracranial aneurysms. Neurosurgery. 1999; 45: 1137–1146.[CrossRef][Medline] [Order article via Infotrieve]
  10. Bruno G, Todor R, Lewis I, Chyatte D. Vascular extracellular matrix remodeling in cerebral aneurysms. J Neurosurg. 1998; 89: 431–440.[Medline] [Order article via Infotrieve]
  11. Nakajima N, Nagahiro S, Sano T, Satomi J, Satoh K. Phenotypic modulation of smooth muscle cells in human cerebral aneurysmal walls. Acta Neuropathol (Berl). 2000; 100: 475–480.[CrossRef][Medline] [Order article via Infotrieve]
  12. Hara A, Yoshimi N, Mori H. Evidence for apoptosis in human intracranial aneurysms. Neurol Res. 1998; 20: 127–130.[Medline] [Order article via Infotrieve]
  13. Kosierkiewicz TA, Factor SM, Dickson DW. Immunocytochemical studies of atherosclerotic lesions of cerebral berry aneurysms. J Neuropathol Exp Neurol. 1994; 53: 399–406.[Medline] [Order article via Infotrieve]
  14. Murayama Y, Tateshima S, Gonzalez NR, Vinuela F. Matrix and bioabsorbable polymeric coils accelerate healing of intracranial aneurysms: long-term experimental study. Stroke. 2003; 34: 2031–2037.[Abstract/Free Full Text]
  15. Hatano T, Miyamoto S, Kawakami O, Yamada K, Hashimoto N, Tabata Y. Acceleration of aneurysm healing by controlled release of basic fibroblast growth factor with the use of polyethylene terephthalate fiber coils coated with gelatin hydrogel. Neurosurgery. 2003; 53: 393–400.[CrossRef][Medline] [Order article via Infotrieve]
  16. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension. 2001; 38: 581–587.[Abstract/Free Full Text]
  17. Okamoto E, Couse T, De Leon H, Vinten-Johansen J, Goodman RB, Scott NA, Wilcox JN. Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation. 2001; 104: 2228–2235.[Abstract/Free Full Text]
  18. Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res. 2002; 91: 281–291.Review.[Abstract/Free Full Text]
  19. Nussel F, Wegmuller H, Huber P. Morphological and haemodynamic aspects of cerebral aneurysms. Acta Neurochir (Wien). 1993; 120: 1–6.[CrossRef][Medline] [Order article via Infotrieve]
  20. Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC, Mason DY. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol. 1990; 43: 752–757.[Abstract/Free Full Text]
  21. Seidal T, Angervall L, Kindblom LG. Expression of muscle-specific actins and myosin in light microscopically undifferentiated small and dark cell malignancies of soft tissues. APMIS. 1990; 98: 1105–1112.[Medline] [Order article via Infotrieve]
  22. Frid MG, Printesva OY, Chiavegato A, Faggin E, Scatena M, Koteliansky VE, Pauletto P, Glukhova MA, Sartore S. Myosin heavy-chain isoform composition and distribution in developing and adult human aortic smooth muscle. J Vasc Res. 1993; 30: 279–292.[Medline] [Order article via Infotrieve]
  23. Esterre P, Melin M, Serrar M, Grimaud JA. New specific markers of human and mouse fibroblasts. Cell Mol Biol. 1992; 38: 297–301.[Medline] [Order article via Infotrieve]
  24. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992; 168: 357–363.[CrossRef][Medline] [Order article via Infotrieve]
  25. Richter T, Nahrig J, Komminoth P, Kowolik J, Werner M. Protocol for ultrarapid immunostaining of frozen sections. J Clin Pathol. 1999; 52: 461–463.[Abstract]
  26. Boutin B, Matsuguchi L, Lebon P, Ponsot G, Arthuis C. Immunohistochemical analysis of brain macrophages in adrenoleukodystrophy. Neuropediatrics. 1989; 20: 202–206.[Medline] [Order article via Infotrieve]
  27. Pulford K, Micklem K, McCarthy S, Cordell J, Jones M, Mason DY. A monocyte/macrophage antigen recognized by the four antibodies GHI/61, Ber-MAC3, Ki-M8 and SM4. Immunology. 1992; 75: 588–595.[Medline] [Order article via Infotrieve]
  28. Chang CC, Eshoa C, Kampalath B, Shidham VB, Perkins S. Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry. Correlation with blast differentiation in bone marrow. Am J Clin Pathol. 2000; 114: 807–811.[Abstract/Free Full Text]
  29. Juvela S. Minor leak before rupture of an intracranial aneurysm and subarachnoid hemorrhage of unknown etiology. Neurosurgery. 1992; 30: 7–11.[Medline] [Order article via Infotrieve]
  30. Juvela S. Natural history of unruptured intracranial aneurysms: risks for aneurysm formation, growth, and rupture. Acta Neurochir Suppl. 2002; 82: 27–30.[Medline] [Order article via Infotrieve]
  31. Zempo N, Kenagy RD, Au YP, Bendeck M, Clowes MM, Reidy MA, Clowes AW. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J Vasc Surg. 1994; 20: 209–217.[Medline] [Order article via Infotrieve]
  32. Jonasson L, Holm J, Hansson G. Smooth muscle cells express Ia antigens during arterial response to injury. Lab Invest. 1988; 58: 310–315.[Medline] [Order article via Infotrieve]
  33. Zempo N, Koyama N, Kenagy RD, Lea HJ, Clowes AW. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol. 1996; 16: 28–33.[Abstract/Free Full Text]
  34. Frosen J, Calderon-Ramirez L, Hayry P, Myllarniemi M. Quantitation of cell migration in a rat carotid artery balloon injury model. Indications for a perivascular origin of the neointimal cells. Cardiovasc Drugs Ther. 2001; 15: 437–444.[CrossRef][Medline] [Order article via Infotrieve]



This article has been cited by other articles:


Home page
StrokeHome page
J. G. Isaksen, Y. Bazilevs, T. Kvamsdal, Y. Zhang, J. H. Kaspersen, K. Waterloo, B. Romner, and T. Ingebrigtsen
Determination of Wall Tension in Cerebral Artery Aneurysms by Numerical Simulation
Stroke, December 1, 2008; 39(12): 3172 - 3178.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Z. Touat, L. Lepage, V. Ollivier, P. Nataf, U. Hvass, J. Labreuche, M. Jandrot-Perrus, J.-B. Michel, and G. Jondeau
Dilation-Dependent Activation of Platelets and Prothrombin in Human Thoracic Ascending Aortic Aneurysm
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 940 - 946.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. Laaksamo, R. Tulamo, M. Baumann, R. Dashti, J. Hernesniemi, S. Juvela, M. Niemela, and A. Laakso
Involvement of Mitogen-Activated Protein Kinase Signaling in Growth and Rupture of Human Intracranial Aneurysms
Stroke, March 1, 2008; 39(3): 886 - 892.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Y. M. Ruigrok and G. J.E. Rinkel
Genetics of Intracranial Aneurysms
Stroke, March 1, 2008; 39(3): 1049 - 1055.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Weinsheimer, K. A.B. Goddard, A. R. Parrado, Q. Lu, M. Sinha, E. R. Lebedeva, A. Ronkainen, M. Niemela, E. K. Khusnutdinova, R. I. Khusainova, et al.
Association of Kallikrein Gene Polymorphisms With Intracranial Aneurysms
Stroke, October 1, 2007; 38(10): 2670 - 2676.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
A.K. Wakhloo, M.J. Gounis, J.S. Sandhu, N. Akkawi, A.E. Schenck, and I. Linfante
Complex-Shaped Platinum Coils for Brain Aneurysms: Higher Packing Density, Improved Biomechanical Stability, and Midterm Angiographic Outcome
AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1395 - 1400.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Aoki, H. Kataoka, M. Morimoto, K. Nozaki, and N. Hashimoto
Macrophage-Derived Matrix Metalloproteinase-2 and -9 Promote the Progression of Cerebral Aneurysms in Rats
Stroke, January 1, 2007; 38(1): 162 - 169.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Sarda-Mantel, M. Coutard, F. Rouzet, O. Raguin, J.-M. Vrigneaud, F. Hervatin, G. Martet, Z. Touat, P. Merlet, D. Le Guludec, et al.
99mTc-Annexin-V Functional Imaging of Luminal Thrombus Activity in Abdominal Aortic Aneurysms
Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2153 - 2159.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Z. Touat, V. Ollivier, J. Dai, M.-G. Huisse, A. Bezeaud, U. Sebbag, T. Palombi, P. Rossignol, O. Meilhac, M.-C. Guillin, et al.
Renewal of Mural Thrombus Releases Plasma Markers and Is Involved in Aortic Abdominal Aneurysm Evolution
Am. J. Pathol., March 1, 2006; 168(3): 1022 - 1030.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
T. Satoh, M. Omi, C. Ohsako, A. Katsumata, Y. Yoshimoto, S. Tsuchimoto, K. Onoda, K. Tokunaga, K. Sugiu, and I. Date
Influence of Perianeurysmal Environment on the Deformation and Bleb Formation of the Unruptured Cerebral Aneurysm: Assessment with Fusion Imaging of 3D MR Cisternography and 3D MR Angiography
AJNR Am. J. Neuroradiol., September 1, 2005; 26(8): 2010 - 2018.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/10/2287    most recent
01.STR.0000140636.30204.dav1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frösen, J.
Right arrow Articles by Jääskeläinen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frösen, J.
Right arrow Articles by Jääskeläinen, J.
Related Collections
Right arrow Smooth muscle proliferation and differentiation
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage